Fundraising FoxRheumasense
1 known investors
Find your way into Rheumasense
42 people in our graph share verified history with the Rheumasense team — schools, employers, funds. One of them is your warm intro.
John Aballiunlockedknows Jen Skeen · together at GenomeDx Biosciences Inc. (overlapped)
×6knows the team · via renegade.bio
knows the team · via DeVry University
×3knows the team · via University of Illinois College of Medicine
knows the team · via Asuragen
Rheumasense develops clinical diagnostic testing technology aimed at transforming the management and care of rheumatoid arthritis. The company is advancing its diagnostic platform toward FDA submission and commercialization.
Founders & leadership
JM
JS
Jen SkeenCEOJen Skeen is CEO of Rheumasense, a clinical diagnostics company developing testing technology for rheumatoid arthritis management. She brings extensive biotechnology and laboratory operations experience, including expertise in molecular diagnostics, regulatory affairs, and commercialization.
Investors · 1
NLClisted by NLCAmsterdam
How we know: NLC's portfolio page · Not right? Tell us
Frequently asked questions
- What does Rheumasense do?
- Rheumasense develops clinical diagnostic testing technology aimed at transforming the management and care of rheumatoid arthritis. The company is advancing its diagnostic platform toward FDA submission and commercialization.
- Who founded Rheumasense?
- Rheumasense was founded by John M. Davis III.
- Who are Rheumasense's investors?
- Rheumasense's investors include NLC.